Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Sees Significant Decline in Short Interest

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 3,880 shares, a decrease of 68.0% from the June 15th total of 12,119 shares. Based on an average trading volume of 24,174 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.0% of the shares of the company are sold short.

Defiance Daily Target 2X Long LMND ETF Stock Performance

LMNX stock traded down $0.01 on Friday, reaching $18.59. 8,274 shares of the company were exchanged, compared to its average volume of 43,894. Defiance Daily Target 2X Long LMND ETF has a 12 month low of $10.17 and a 12 month high of $55.00. The stock’s fifty day moving average price is $14.13 and its 200 day moving average price is $21.46. The firm has a market capitalization of $6.88 million, a PE ratio of 36.45 and a beta of 9.35. The company has a debt-to-equity ratio of 0.52, a current ratio of 8.37 and a quick ratio of 6.08.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.